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Abstract The D-enantiomers of amino acids have been
thought to have relatively minor functions in biological
processes. While L-amino acids clearly predominate in nat-
ure, D-amino acids are sometimes found in proteins that are
not synthesized by ribosomes, and D-Ala and D-Glu are
routinely found in the peptidoglycan cell wall of bacteria.
Here, we review recent ﬁndings showing that D-amino acids
have previously unappreciated regulatory roles in the bac-
terial kingdom. Many diverse bacterial phyla synthesize and
release D-amino acids, including D-Met and D-Leu, which
were not previously known to be made. These noncanonical
D-amino acids regulate cell wall remodeling in stationary
phase and cause bioﬁlm dispersal in aging bacterial com-
munities. Elucidating the mechanisms by which D-amino
acids govern cell wall remodeling and bioﬁlm disassembly
will undoubtedly reveal new paradigms for understanding
howextracytoplasmicprocessesareregulatedaswellaslead
to development of novel therapeutics.
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NRP Nonribosomal peptide
PG Peptidoglycan
GlcNAc N-acetyl glucosamine
MurNAc N-acetylmuramic acid
PBPs Penicillin-binding proteins
PLP Pyridoxal-5-phosphate
BsrV Broad spectrum racemase in Vibrio
Introduction
Objects are described as chiral if their reﬂected image in a
mirror cannot be superimposed on the original. The term
chiral is derived from the Greek word for hand, veiq,a s
human hands provide a prime example of chirality. While
verysimilarinalmostallcharacteristics,the mirrorimageof
a left hand—the right hand—cannot be superimposed on
itselfandinteractswithotherobjectsinadistinctmanner[1].
Natural objects, such as vertebrate appendages, that exhibit
chiralityare readily apparent. Chirality is also widespread at
the molecular level. Remarkably, in 1848 at the age of 25,
before he carriedout hispioneering studies in microbiology,
the great French scientist Louis Pasteur (1822–1895) dis-
covered molecular chirality in mirror-image tartaric acid
crystals(revisitedin[2]).Nineyearslater,whilestudyingthe
fermentation of tartaric acid by microorganisms, Pasteur
discovered that one mirror image of tartaric acid was con-
sumed with greater preference over the other [2, 3]. In the
ensuing 150 years, the great importance of molecular chi-
rality in many biochemical processes has become clear.
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123The two mirror images of a chiral molecule are referred
to as optical isomers or enantiomers (from the Greek
evhqo ´1, ‘‘enemy’’). Most physical properties of enantiomers
are identical; however, they have distinct interactions with
plane-polarized light. When plane-polarized light passes
through a solution of chiral molecules, one enantiomer
rotates the plane of polarization in a counterclockwise (left-
hand) direction whereas the other enantiomer rotates the
plane of polarization in a clockwise (right-hand) direction.
In biological molecules, the most common basis of chirality
is a carbon atom bonded to four different groups, which is
termed a stereocenter (or chiral center). The three-dimen-
sional arrangement of the atoms bound to a chiral center can
be used to describe a molecule’s chirality. Different
nomenclature systems have been developed to describe the
chirality of molecules, but D- and L- preﬁxes are generally
used for amino acids and sugars as described in [4]. The
D/L nomenclature for amino acid conﬁguration does not
refer to the optical activity of the amino acid per se, but
rather to the optical activity of the glyceraldehyde isomer
that the amino acid can be overlayed upon. The structures of
the L- and D-enantiomers of alanine are shown in Fig. 1.
While chemical synthesis routinely yields both enanti-
omers, most enzymes display marked substrate selectivity,
and as a consequence many biochemical processes gener-
ally utilize and yield particular enantiomers. For example,
L-amino acids are the predominant building blocks of
proteins; D-amino acids cannot be incorporated into pro-
teins via ribosomal synthesis. Similarly, nearly all naturally
occurring monosaccharides exist as D-sugars. The origins
of enantiospeciﬁcity in biological processes are unclear,
but it has been proposed that enantiomerically enriched
organic compounds were critical for the generation of
proto-life forms [5–7].
Even though L-amino acids are the dominant substrates
for ribosome-based protein synthesis, several roles for
D-amino acids in other biological processes have been
described. For example, D-aspartate is a major regulator of
adultneurogenesis[8]and D-serineactsasaco-agonistofthe
N-methyl D-aspartate-type glutamate receptors in the brain,
which are involved in learning, memory, and behavior in
mammals [9–11]. D-serine is also the most abundant amino
acid in human urine and alters gene expression of uropath-
ogenic Escherichia coli (UPEC) [12].
It was noted more than 50 years ago that, in addition to
free amino acids, some peptides contain D-amino acids [13].
D-conﬁgured residues in peptides provide resistance to pro-
teases, which generally exhibit speciﬁcity for L-amino acid-
containing peptides, and also contribute to their bioactivity
(listed in Tables 1, 2). D-amino acids are incorporated into
the peptides via two different mechanisms. The ﬁrst mech-
anism is posttranslational conversion of L-t oD-amino acids
within peptides that were originally synthesized in ribo-
somes. The second mechanism requires the activity of
nonribosomal peptide (NRP) synthetases, which, unlike
ribosomalpeptidesynthesis,generatespeptidesindependent
of messenger RNA. While posttranslational modiﬁcation
occurs primarily in eukaryotes, NRP synthesis is more fre-
quent in bacteria. For example, dermorphin is an analgesic
1,000 times more potent than morphine [14, 15], achatin-I is
an excitatory neurotransmitter [16–18], and gramicidines
and tyrocidines have antimicrobial activity [19–23]. Con-
sidering that Tables 1 and 2 summarize most of the known
examples in the literature, D-amino acid-containing peptides
seem relatively unusual. However, peptides containing
D-aminoacidshaveprobablybeenoverlooked.Furthermore,
therehavebeenincreasingnumbersofreportsonthissubject
in the last few decades suggesting that there are likely to be
many more yet-to-be-discovered examples of D-amino acids
in nature.
Besides being occasionally incorporated in peptides,
D-amino acids have been known to be utilized as nutrients
to support bacterial growth [24–27], to regulate bacterial
spore germination, and to be components of the bacterial
cell wall. We brieﬂy summarize the latter two previously
recognized roles of D-amino acids below. Then, we discuss
recent ﬁndings showing that D-amino acids have previously
unappreciated regulatory roles in the bacterial kingdom.
D-amino acids and bacterial spore germination
Bacterial sporulation is an adaptive response to environ-
mental stress, such as starvation, and involves a ﬁnely
L-Alanine D-Alanine
α α
Fig. 1 Chirality of alanine. Ball-and-sticks representation of the
enantiomeric forms of the amino acid alanine. Carboxyl group is
colored in red, amino group in blue, and R-group in yellow. Chiral
carbon is labeled as a. The molecules were designed with ChemDraw
Ultra 12.0 and Chem3D Pro 12.0 software
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123Table 1 D-amino acids in eukaryotic peptides
Peptide D-amino acid
(position)
Source Activity Reference
Dermorphin D-Ala (2nd) Phyllomedusa sauvagei
(skin secretions of
Argentinian tree frog)
Binds to l-type opiate receptors
and acts as an analgesic 1,000
times more powerful than
morphine
[14, 15]
Deltorphins D-Met or D-Ala (2nd) Phyllomedusa species
(skin secretions)
Binds to d-type opiate receptors [107, 108]
Bombinins and
bombinins H
D-allo-Ile (2nd) Bombinatoridae
(skin secretions
of frogs)
Antimicrobial and hemolytic
activity
[109–111]
Achatin-I D-Phe (2nd) Achatina fulica (ganglia
and atrium of African
snail)
Excitatory neurotransmitter
controlling muscle contraction
[16–18]
Fucilin D-Asn (2nd) A. fulica (ganglia of African
snail)
Excitatory neurotransmitter
controlling penis contraction
[112, 113]
Contryphans D-Trp (3rd or 4th) Conus purpurascens and
C. radiatus
(venom of cone snail)
Causes tremor and mucous
secretions when injected into
ﬁsh
[114–116]
D-Leu (5th)
FRF amide family D-Leu (2nd) Bivalves Stimulates muscle contraction [117]
Crustacean
hyperglycemic
hormone
D-Phe (3rd) Decapod crustaceans Neurohormone controlling
hyperglycemia
[118, 119]
x-Agatoxin-IVB D-Ser (46th) Agelenopsis aperta (venom
of funnel-web spider)
Blocks voltage-sensitive calcium
channels
[120, 121]
Paecilodepsipeptide A Three D-amino acid residues
including an unusual
O-prenyl-D-Tyr
Insect pathogenic fungus
Paecilomyces
cinnamomeus BCC 9616
Activity against the malarial
parasite Plasmodium falciparum
K1; cytotoxicity to cancer cell
lines (KB and BC)
[122]
Table 2 D-amino acids in bacterial peptides
Peptide D-amino acid (position) Source Activity Reference
Gramicidine S D-Phe (4th, 9th) Bacillus brevis
(antimicrobial peptides)
Membrane disruption of lipid bilayer [19, 20]
Gramicidine D D-Leu (4th, 10th, 12th, 14th) B. brevis (antimicrobial
peptides)
Permeabilizes lipid membranes by forming
ion channels that disrupt ion gradient
[20, 21]
D-Val (6th, 8th)
Tyrocidines D-Phe (1st) B. brevis (antimicrobial
peptides)
Permeabilizes lipid membranes [22, 23]
D-Phe or D-Tyr (4th)
Daptomycin
(Cubicin)
D-Ala (8th) Streptomycetes
(S. roseosporus)
Bactericidal activity [123–125]
Lipopeptidolactones Arthrofactin (7 D-amino acids
of the 11)
Pseudomonas strains Biosurfactants [126–132]
Syringomycin (2 D-amino acids
of the 9)
Syringopeptin (about 70% of the
sequence is in D-conﬁguration)
DD-diketopiperazines Only D-amino acids Bacterial strains CF-20
(CECT5719) and C-148
(CECT5718), isolated
from cultures of larvae of
mollusks
Strong antibiotic activity against Vibrio
anguillarum
[133]
Gassericin A 1 D-Ala residue Lactobacillus gasseri
LA39
Antimicrobial activity against Listeria
monocytogenes, Bacillus cereus,
and S. aureus
[134–136]
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123controlled developmental program. Initiation of sporulation
leadstoasymmetriccelldivisionproducingamothercelland
foresporewithdistinctcellfates.Theforesporedevelopsinto
the spore, whereas the mother cell nurtures the spore but
ultimately lyses through programmed cell death [28].
Bacterial spores are metabolically dormant and resis-
tant to a number of harsh environments including heat,
radiation, desiccation, pH extremes, and toxic chemicals
[29]. This remarkable resistance is provided by a tough
multilayered cell wall [30]. In the presence of speciﬁc
germinants such as L-alanine or other nutrients, spores
can reactivate metabolism and grow vegetatively. In
1949, it was discovered that D-alanine was a potent
inhibitor of spore germination in many Bacillus species
[31]. Subsequent work since this discovery has revealed
that Bacillus species utilize D-alanine as an auto-inhibitor
of spore germination at high spore density. This activity
is mediated through expression of an alanine racemase in
the spore exosporium that converts a spore germinant
(L-Ala) to an anti-germinant (D-Ala) [32]. A nutrient
receptor is responsible for recognition of L-Ala, and it
has been suggested that D-Ala antagonizes L-Ala binding
to this receptor [33]. Presumably, this mechanism of
auto-inhibition is an evolutionary adaptation to prevent
premature germination under low nutrient conditions and
high population density, an environmental condition that
would lead to rapid nutrient depletion and cell death.
Recent work has also suggested that D-Ala alters the
kinetics of germination in vivo to enhance the efﬁciency
and timing of infection [34]. D-His has also been
implicated as a germination inhibitor of Bacillus an-
thracis infection in murine macrophages [35], however
its mechanism of action and whether it is physiologically
produced by B. anthracis is unknown.
D-amino acids in peptidoglycan
Bacteria have a formidable ability to withstand many
physical, chemical, and biological insults. In large part,
this is due to the peptidoglycan (PG) cell wall, which
imparts to the cell its shape, strength, and resistance to
osmotic pressure [36–38]. PG also serves as a scaffold
for anchoring other cell envelope components [39, 40].
PG (also known as murein) is found on the outside of
the cytoplasmic membrane of almost all bacteria [36, 41,
42]. It is a strong yet ﬂexible net-like polymer composed
of linear glycan strands made up of repeating disaccha-
ride units of N-acetyl glucosamine (GlcNAc) and
N-acetylmuramic acid (MurNAc) cross-linked by short
peptides (Fig. 2). PG is essential for cell viability and
therefore its synthesis and turnover must be tightly
controlled; otherwise, the mechanical stability of the cell
wall and cell integrity would be compromised. In gram-
negative bacteria, a single layer of PG, which is found in
the periplasmic space between the inner and outer cell
membranes, is sufﬁcient to maintain the cell’s mechan-
ical stability [43]. In gram-positive bacteria, which lack
an outer cell membrane, the cell wall is thicker, con-
sisting of many layers of PG.
The biosynthesis of PG is divided into three stages
(Fig. 2).Intheﬁrststep,thePGprecursorsnucleotidesugar-
linked UDP-MurNAc-pentapeptide and UDP-GlcNAc are
synthesized in the cytoplasm [44]. Second, lipid intermedi-
ates of these precursors are formed by transferring the
phospho-MurNAc-pentapeptide moiety of UDP-MurNAc-
pentapeptide to the membrane acceptor bactoprenyl-P,
yielding lipid I. Subsequently, GlcNAc from UDP-GlcNAc
is added to lipid I, yielding lipid II. The lipid II intermediate
enables the cell to transport the hydrophilic precursors from
the aqueous environment of the cytoplasm through the
hydrophobic membrane, where they can act as substrates for
incorporation into the PG polymer [45, 46]. PG polymeri-
zation, the third stage of PG biosynthesis, occurs outside of
thecellmembraneintheperiplasmicspaceofgram-negative
bacteria and outside the cell entirely in gram-positive
organisms. Polymerization is carried out by penicillin-
binding proteins (PBPs). These enzymes catalyze both the
transglycosylationandtranspeptidationreactionsrequiredto
incorporatenewmuropeptidesintothePGpolymer[47–50].
One of the most striking features of PG composition is
the presence of D-amino acids in the stem peptides (Fig. 2)
[51]. D-amino acids contribute to the architecture of the
murein and, more importantly, provide resistance to most
known proteases. Thus, the presence of D-amino acids in
PG likely constitutes a bacterial adaptation to protect a
vital cellular structure. D-Ala and D-Glu are by far the most
common D-amino acids present in the bacterial cell wall;
however, the PG of some bacteria include other D-amino
acids, such as D-Asp in Lactococcus [52] and Enterococcus
[53], and D-Ser in vancomycin-resistant Staphylococcus
aureus [54–56]. In some cases, such substitutions enable
bacteria to tolerate bactericidal agents from the environ-
ment [57].
Production of D-amino acids
Since L-amino acids are the predominant amino acids
found in living organisms, typically they act as the sub-
strate for generation of D-amino acids. L-t oD-conversion
occurs by the action of racemases that change the stereo-
chemistry of the chiral a-carbon atom in amino acids [58].
Amino acid racemases are classiﬁed into two groups,
pyridoxal-5-phosphate (PLP)-dependent and PLP-inde-
pendent enzymes, with distinct reaction mechanisms.
820 F. Cava et al.
123PLP-dependent amino acid racemases
Alanine racemases
Alanine racemases use a PLP-dependent mechanism to
deprotonate the a-carbon of alanine. Reprotonation of the
a-carbon on the opposite side generates the antipodal
amino acid (Fig. 3a). In the racemase molecule, PLP is
bound to a Lys residue to form an internal Schiff base.
The substrate alanine molecule reacts with PLP by
transaldimination to form an external Schiff base.
Abstraction of the a-hydrogen of the substrate amino
acid moiety of the Schiff base generates an anionic form
that is stabilized as a quinoid intermediate with the PLP
moiety (Fig. 3c). This intermediate is subsequently pro-
tonated and releases the antipodal form of alanine
through a second transaldimination reaction with the
same Lys residue involved in the initial reaction, thus
regenerating the enzyme (Fig. 3c) [59]. One- and two-
base reaction mechanisms have been proposed for the
abstraction/addition of the a-hydrogen. In the former the
a-hydrogen of both isomers is abstracted and added
with a single catalytic residue (Lys). In the latter the
a-hydrogen of either D-alanine or L-alanine is abstracted
and added by a different catalytic residue (Tyr and Lys,
respectively). Although the two-base mechanism is more
probable, further experimentation is under way to show
this conclusively [60].
Most bacteria encode two different alanine racemases,
DadB and Alr. While both racemases use the same reaction
mechanism, they are components of distinct molecular
pathways. DadB participates in L-Ala catabolism, produc-
ing D-Ala to be used as a substrate to form pyruvate via a
D-Ala dehydrogenase. In contrast, Alr generates the D-Ala
that is utilized in formation of muropeptide precursors for
PG synthesis [61, 62].
Fig. 2 Biosynthesis of
peptidoglycan (PG). General
scheme of PG synthesis in gram
negative bacteria. PG synthesis
is initiated with the synthesis of
the disaccharide pentapeptide
precursors in the cytosol
(GlcNAc-MurNAc-L-Ala-D-
Glu-DAP-D-Ala-D-Ala) [42].
Then, PG precursors are
translocated to the periplasmic
space facilitated by the
formation of lipidic complexes
with bactoprenol [43, 44]. Once
in the periplasm, PG monomers
are incorporated into the murein
polymer by transglycosylation
and transpeptidation reactions
carried out by the activity of the
penicillin-binding proteins
(PBPs) [45–48]. Also PBP
activities (murein hydrolases)
can affect the length of the stem
peptides, depicted as D-Ala
between brackets [43]. IM Inner
membrane, OM outer membrane
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123Serine racemase
Bacterial serine racemases are homologues of alanine
racemases and play an important role in resistance to
vancomycin [54, 56], a glycopeptide antibiotic that inhibits
PG synthesis by binding to the D-Ala-D-Ala moiety in
muropeptide precursors. In enterococci, vancomycin
resistance arises through modiﬁcation of the vancomycin
target site from D-Ala-D-Ala to either D-Ala-D-lactate or
D-Ala-D-Ser [63]. D-Ser is generated from L-Ser by VanT, a
serine racemase, which, like alanine racemase, is also PLP-
dependent and probably uses a two-base catalyzed reaction.
The similarity of VanT to alanine racemase suggests that
the two enzymes share a common evolutionary history
[64].
PLP-independent amino acid racemases
Glutamate racemase
Like D-Ala, D-Glu is a component of the PG cell wall in
bacteria, but this D-amino acid is produced by a PLP-
independent racemase. Similar to alanine racemases,
glutamate racemases are thought to follow a two-base
mechanism, however, two cysteines have been suggested
to be involved in the catalysis of the latter [65–67]
(Fig. 3b).
In some organisms, such as E. coli, expression of glu-
tamate racemase is activated 100-fold in the presence of
UDP-MurNAc-L-Ala. This intermediate is ligated to D-Glu
in generating PG precursor units, lipid I and lipid II. Thus,
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Fig. 3 Mechanism of amino
acid racemase reactions. a PLP-
dependent alanine racemase
(AlaRac) and b PLP-
independent glutamate
racemase (GluRac) reactions are
depicted showing the amino
acidic residues of the enzymes
that participate in the
stereochemical transformation
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shown in brackets. c Schematic
of the catalytic mechanism of
the PLP-dependent alanine
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molecules were designed with
ChemDraw Ultra 12.0 software
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123expression of the glutamate racemase is regulated by the
factors that require its presence [68, 69].
Bacillus subtilis encodes two glutamate racemases, Glr
and YrpC. Though both proteins have similar biochemical
properties, Glr is mainly involved in D-glutamate synthesis
for poly-c-D-glutamate, a structural component of the spore
capsule, whereas YrpC is the racemase that creates D-Glu
for the cell wall PG [70, 71].
Aspartate and proline racemases
D-Asp occurs in the PG layer of some bacterial cell walls
and is produced from L-Asp by an aspartate racemase. The
enzyme is present in various gram-positive bacteria,
including Lactococcus lactis [52], Enterococcus faecium
[53], Lactobacillus fermenti [72], and Streptococcus fae-
calis [73], as well as some archea [74]. Like glutamate
racemase, aspartate racemase requires no cofactors, con-
tains an essential cysteine residue, and has been proposed
to act via a two-base mechanism to remove and return the
a-proton of the substrate [75].
Proline racemase is also a member of the PLP-inde-
pendent enzyme family. Proline racemases have been
identiﬁed in Clostridium difﬁcile and Clostridium stick-
landii. Currently, it is not known if D-Pro is a component of
PG in these spore-forming organisms, but it has been
hypothesized that D-Pro may enable these pathogens to
evade the host immune response [76].
Newly appreciated regulatory roles for D-amino acids
in bacteria
As outlined above, the roles of D-amino acids in bacteria
were thought to be fairly limited. However, recently it has
become clear that D-amino acids are synthesized and
released by bacteria from diverse phyla, at up to millimolar
concentrations [77]. Furthermore, released D-amino acids
function to regulate cell wall chemistry and architecture as
well as bioﬁlm development in bacteria [78]. These ﬁnd-
ings and their implications are discussed below.
D-amino acids govern cell wall remodeling in bacteria
Although PG functions as an exoskeleton, bacterial growth
and survival depends on PG plasticity [41, 42, 79]. When
bacteria grow, covalent bonds in the PG polymer must be
cleaved by murein hydrolases and new bonds formed to
insert new subunits into the sacculus. Furthermore, new PG
synthesis is crucial for the formation of the septum during
cell division (with subsequent generation of the new poles
in the daughter cells) [80] and for sporulation/germination
PG remodeling [29, 81, 82]. Finally, in times of stress, PG
also can be remodeled. For example, many rod-shaped
bacteria reorganize their PG in stationary phase, becoming
smaller and more coccoid in shape [83]. Currently, there is
relatively little understanding of the factors that govern PG
remodeling during exponential growth; however, D-amino
acids were recently shown to control changes in PG com-
position and architecture as cells enter stationary phase (see
below).
More than six decades ago, high concentrations of exog-
enous D-amino acids were found to inhibit bacterial growth
[84–86]. This effect, which was attributed to alterations in
PGmetabolisminthetreatedcells[87–90],requiredaddition
of seemingly nonphysiological levels of amino acids, and
hence was not thought to be biologically meaningful; how-
ever,itdidinspiretheuseofexogenouslyaddedcomponents
to investigate murein segregation. De Pedro and colleagues
demonstrated that low concentrations of D-Cys were rela-
tively innocuous to cells but that several bacterial species
incorporated this sulfhydryl-bearing amino acid into murein
[89, 90]. Immunodetection of the -SH groups in puriﬁed
sacculi enabled the distribution of D-Cys in PG to be tracked
[91], and such studies have provided valuable insights
intocellgrowth,polarity,andPGsynthesisandmaintenance
[92, 93].
Discovery of production and release of D-amino acids
by bacteria
Our group recently made the unexpected discovery that
many diverse phyla of bacteria produce types of D-amino
acids that were not previously known to be synthesized and
release them into the environment [77]. We made this
surprising ﬁnding while investigating the genetic basis for
the curved rod-shape of Vibrio cholerae, the gram-negative
bacterium that causes cholera. A genetic screen for
V. cholerae with altered cell shape yielded a mutant that
exhibited a growth phase-dependent cell morphology
defect. We observed that nearly all mrcA mutant cells in
stationary phase cultures were spherical, although their
morphology did not differ from that of wild-type cells
during exponential growth. The mrcA gene encodes
PBP1A, an inner membrane-anchored enzyme that elon-
gates the glycan chains and establishes the cross-links
between the peptides of the PG [37]. Thus, PBP1A-
mediated PG synthesis appears to be required for the
maintenance of V. cholerae rod shape in stationary phase.
In contrast, deletion of mrcB, which encodes PBP1B, had
no effect on V. cholerae morphology suggesting that these
two homologous enzymes have clearly separable functions
[77].
We hypothesized that the rod-to-sphere transition of the
mrcA cells might be stimulated by an extracellular factor
present in stationary phase supernatants, since the
Emerging roles for D-amino acids 823
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saturated and entered stationary phase. In fact, exponen-
tially growing rod-shaped mrcA cells rapidly became
spherical when incubated in a cell-free supernatant from
stationary phase cultures. We puriﬁed the sphere-inducing
component and identiﬁed that the active factors were four
amino acids: Met, Leu, Val, and Ile. The D- rather than
L-forms of these particular amino acids were the active
agents in V. cholerae supernatants that inﬂuenced mrcA’s
morphology. Remarkably, stationary phase V. cholerae
supernatants contained a *1 mM total concentration of
these four D-amino acids, an amount sufﬁcient to account
for the sphere-inducing activity in the supernatants. Except
for D-Pro and D-Gln, other D-amino acids also had some
capacity to stimulate the mrcA mutant’s shape transition
from rod to sphere, suggesting that sphere-inducing activity
is promoted by the chirality rather than the side chain of the
amino acid [77].
BsrV racemase
Genomic analysis allowed us to identify a novel V. cholerae
racemase that proved to be necessary and sufﬁcient for the
synthesis of the unusual D-amino acids in V. cholerae
supernatants. Besides the two genes that encode the
V. cholerae Glu and Ala racemases, the V. cholerae genome
contains an additional gene (vc1312) that encodes a putative
PLP-dependent amino acid racemase. A strain with a dele-
tion of this gene was highly defective in the production of
D-Met, D-Leu, D-Val,and D-Ile,suggestingthatitencodesthe
principal racemase for the generation of these four D-amino
acids. This enzyme, which was named broad spectrum rac-
emase in Vibrio (BsrV) also exhibits in vitro racemase
activity for these D-amino acids conﬁrming BsrV as a broad
spectrum racemase [77]. Since extracellular D-amino acids
were not detected in supernatants from exponential phase
cultures of wild-type cells, BsrV is likely only active during
stationaryphase.Inaddition,unlikenearlyallotherbacterial
amino acid racemases, which are cytoplasmic, the BsrV
racemasewasfoundexclusivelyintheperiplasm,suggesting
that D-amino acids produced by BsrV primarily act on peri-
plasmic targets [77].
Notably, we found that the release of D-amino acids into
the media is not limited to V. cholerae and other vibrios;
instead, stationary phase supernatants from many species
representing diverse phyla including B. subtilis, S. aureus,
Pseudomonas aeruginosa, and Deinococcus radiodurans
contained different D-amino acids. Consistent with this
observation, most bacterial genomes appear to encode one
or more amino acid racemases in addition to the enzymes
required to generate D-Ala and D-Glu for PG synthesis [77].
This suggests that production of broad spectrum racemases
may be a conserved trait amongst diverse bacteria.
D-amino acids regulate peptidoglycan composition,
amount, and strength
Even though the morphology of wild-type cells was not
altered by D-amino acids, we hypothesized that the
production of D-amino acids by wild-type V. cholerae
has an important physiological role since their generation
represents a signiﬁcant metabolic expenditure. Several
observations supported the idea that release of nonca-
nonical D-amino acids could regulate cell wall
remodeling. First, D-amino acids (principally D-Ala and
D-Glu) are known to be cell wall components, and thus it
seemed reasonable that additional D-amino acids could
inﬂuence PG metabolism. Second, we observed that
wild-type V. cholerae cells became spherical if D-amino
acids were supplemented with b-lactam antibiotics. Since
PG is the principal determinant of bacterial cell shape,
these observations suggested that D-amino acids in
combination with either genetic (e.g., deletion of mrcA)
or chemical inactivation of PBPs lead to weakened PG
that is unable to maintain V. cholerae’s rod shape.
Finally, as mentioned above, previous work by de Pedro
and colleagues revealed that exogenous D-Cys or D-Met
could (at high concentrations) be incorporated into PG
[89–91, 94].
We compared the chemical composition, structure, and
amount of PG isolated from stationary phase wild-type and
bsrV V. cholerae to ascertain the effects of the physiologic
production of D-amino acids on PG metabolism. Remark-
ably, the bsrV mutant, which fails to produce and release
signiﬁcant amounts of D-Met, D-Leu, D-Val, and D-Ile, but
still produces D-Ala and D-Glu, contained twice the amount
of PG found in wild-type cells in stationary phase. Further-
more, exogenous addition of D-amino acids reduced the
amountofPGinV.cholerae.Thus, D-aminoacidsnegatively
regulate the amount of PG produced by V. cholerae in sta-
tionary phase. Moreover, because the accumulation of
D-amino acids coincides with the transition into stationary
phase and appears to downregulate PG synthesis, D-amino
acids may enable coordination of metabolic slowing in cell
wallandcytoplasmiccompartmentswhenresourcesbecome
scarce [77].
The noncanonical D-amino acids are incorporated into
the PG polymer. HPLC-based analyses of muropeptides
from wild-type cells demonstrated that D-Met and D-Leu
were present in PG in stationary phase. D-Met and D-Leu
replaced D-Ala in the fourth position of the peptide bridge
in 3–4% of the stationary phase muropeptides but were not
detected in PG from the bsrV mutant. As previously sug-
gested for the incorporation of exogenous D-amino acid
into the PG [94], the incorporation of physiologically
released D-Met and D-Leu may occur via the action of a
periplasmic, b-lactam-insensitive PG-modifying enzyme.
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123BsrV-generated D-amino acids also inﬂuenced the struc-
ture of stationary phase PG. In comparison to wild-type PG,
theglycanchainsfromthebsrVmutantwere *20%shorter,
andtherewasanapproximately50%reductionintheamount
offull-lengthpentapeptidesandanincreaseintheamountof
trimer muropeptides. Importantly, the changes in PG struc-
ture and abundance in the bsrV mutant appear to reduce PG
strength. Wild-type cells were far more resistant to an
osmotic challenge, suggesting that the PG in wild-type cells
is stronger than that in the bsrV mutant. The osmotic
hypersensitivity of bsrV mutant cells was unexpected since
the bsrVmutant cellscontain twice asmuch PGaswild-type
cells. The ‘‘weakness’’ of the PG in bsrV cells presumably is
a consequence of the alterations in cell wall structure that
resultfromtheabsenceof D-aminoacidsinthesecells.Inthis
regard, variations in the proportions of pentapeptides and
tetrapeptides should have little, if any, effect on the physical
strength of the sacculus (as these peptides do not participate
in bridging). However, the decrease in the length of the
glycan strands in the bsrV mutant could weaken the PG
because the number of covalent bonds closing the net-like
peptidoglycan molecule is reduced. Regardless of the
chemical changes that weaken the PG in the bsrV mutant,
general weakening of the entire sacculus is not required to
bestow osmotic sensitivity, only localized weakening of the
PGwouldbesufﬁcient.Together,theseobservationssuggest
that D-amino acid production by BsrV as cells enter
stationary phase provides an autocrine-like signal for
V. cholerae to remodel its PG and decrease PG synthesis in
adaptation to stationary phase conditions [77].
Regulation of PG by D-amino acids is not limited to
V. cholerae. We found that B. subtilis produces different
D-amino acids than does V. cholerae (mainly D-Phe and
D-Tyr)instationaryphase,butthese D-aminoacidsappearto
inﬂuence PG synthesis and chemistry in similar ways as
D-Metand D-Leu inV. cholerae.Thus, evolutionarily distant
bacteriahaveacommonstrategytomodulatePGsynthesisin
stationary phase through production and release of D-amino
acids. Remarkably, B. subtilis growth was inhibited when
cultured in the presence of exogenous physiologic concen-
trationsof D-aminoacidsproducedbyB.subtilisinstationary
phase.Thissuggeststhat D-aminoacidsmaybeamechanism
to simultaneously slow down growth and PG synthesis as
population density becomes saturating.
Finally, we also found that exogenous physiologic
concentrations of D-Met that are produced by V. cholerae
were incorporated into E. coli PG at the same position in
the peptide bridge. Thus, E. coli is capable of incorporating
noncanonical D-amino acid into its murein sacculus even
though this bacterium does not produce or release nonca-
nonical D-amino acids. Therefore, D-amino acids can also
act as paracrine-like effectors to inﬂuence PG physiology
in species other than those that produce them.
Mechanisms of D-amino acid cell wall regulation
Exactly how D-amino acid-dependent cell wall remodeling
occurs remains to be determined. Incorporation of unusual
D-amino acids (such as D-Met or D-Leu) into the PG
polymer could modulate the strength and ﬂexibility of this
polymer (Fig. 4). Furthermore, PBPs and other enzymes
that modify PG may have altered afﬁnity for and activity
on D-amino acid-modiﬁed muropeptides. However, it is
unlikely that all of the differences in PG composition,
structure, and amount observed between V. cholerae wild-
type and bsrV mutant strains can be solely attributed to the
incorporation of D-amino acids into PG. Supporting this
idea, we found that 2.0 mM D-Ala stimulated the conver-
sion of rod-shaped mrcA cells to spheres, even though
D-Ala is already present at the site where D-Met or D-Leu is
incorporated. Thus, D-Ala, and presumably other D-amino
acids, have effects that are not merely consequences of
their incorporation into PG. In this regard, D-amino acids
likely regulate the periplasmic enzymes that synthesize and
modify the PG polymer. We found that D- but not L-Met
blocks the binding of a ﬂuorescent derivative of penicillin
G to several V. cholerae PBPs [77]. This result suggests
that free amino acids accumulated in the periplasm might
compete with muropeptide moieties for PBP active sites,
thereby serving as regulators of PBP activity. While the
exact identity of these PBPs remains to be determined, this
observation suggests that D-amino acids may be direct
modulators of PBP activity under stationary phase condi-
tions. Further genetic and biochemical analyses of D-amino
acid targets are necessary to deﬁne the mechanism(s) of
D-amino acid action on cell wall PG.
Consistent with reports in other bacterial species [95,
96], we observed additive effects of exogenous D-amino
acids in combination with b-lactam antibiotics on wild-
type V. cholerae shape and growth. For example, the
combination of D-Met with the cephalosporin cefmetazole
or the monobactam aztreonam caused wild-type V. chol-
erae to become spherical (similar to stationary V. cholerae
mrcA), whereas when added independently, only minor
morphological changes were induced. These observations
support the idea that D-amino acids exert regulatory effects
on PG-modifying enzymes.
The challenge of regulating PG composition, amount,
and structure
Regulation of PG amount, chemistry, and architecture
constitutes a particularly challenging issue for the bacterial
cell. This complex polymer as well as the enzymes that
assemble and modify it are located beyond the cytoplasmic
membrane and thus outside of the carefully controlled
milieu of the cytoplasm. D-amino acid production by BsrV
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123in the periplasmic space enables the cell to produce
D-amino acids in the cell compartment (the periplasm)
where they will act. D-amino acid incorporation into the
pre-existing PG polymer in the periplasm can be thought of
as cell wall ‘‘editing.’’ Such post-synthetic regulation of PG
is analogous to posttranslational modiﬁcation of proteins
by glycosylation and to methylation of DNA, processes
that alter the properties/activities of other biopolymers. It is
likely that incorporation of noncanonical D-amino acids
into PG alters the polymers’ physical properties as well as
inﬂuences the ability of D-amino acid-modiﬁed PG to serve
as a substrate for periplasmic PG-modifying enzymes.
Controlling the concentration of D-amino acids in the
periplasm could constitute a reversible mechanism for
inhibiting PBPs, thereby enabling cells to rapidly transition
between states of active and inactive PG metabolism under
changing environmental conditions.
D-amino acids coordinate cell wall metabolism
in bacterial populations
Our work has revealed that noncanonical D-amino acids
regulate cell wall metabolism. Because the accumulation of
D-amino acids coincides with the transition into stationary
phase and appears to downregulate PG synthesis, D-amino
acids may couple metabolic slowing in cell wall and
cytoplasmic compartments under conditions of stress.
Additionally, rapid diffusion of small molecule regulators
like D-amino acids in aqueous environments enables a
quick and synchronized response from the whole bacterial
population. In times of scarce nutrients (and potentially
additional undeﬁned cellular stresses) the release of
extracellular D-amino acids can signal to the whole popu-
lation to regulate PG amount, composition, and strength.
This mechanism may be crucial in nutrient-depleted envi-
ronments where secretion of secondary metabolites such as
organic acids, antibiotics, or small lipids can put the
integrity of the cell at risk. Finally, since bacteria are more
likely to grow in polymicrobial communities than in
monoculture, D-amino acid control may mediate interspe-
cies regulation among bacteria or other organisms that
occupy the same niche. It remains to be seen whether
D-amino acids mediate both mutualistic and competitive
behaviors among different bacteria that share a niche.
D-amino acids control bioﬁlm dispersal
Many bacteria are able to switch between two different
‘‘lifestyles.’’ They can exist as either single (planktonic)
cells or in communities known as bioﬁlms. A bioﬁlm is
deﬁned as a sessile microbial community that adheres to a
solid surface and is surrounded by a bacterially produced
extracellular matrix. This matrix is typically composed of
polysaccharides, but it can also include proteins and/or
DNA. The transition between planktonic and bioﬁlm
growth is regulated by a variety of environmental and
physiological cues, including bacterial cell density, nutrient
availability, and cellular stress [97, 98].
Bioﬁlms are prevalent both in natural environments and
in industrial and hospital settings [99–105]. Bacterial
infections associated with bioﬁlms adherent to medical
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Fig. 4 Model of PG remodeling governed by D-amino acid release in
stationary phase. PG in V. cholerae is composed of linear glycan
strands made up of repeating disaccharide units of GlcNAc and
MurNAc cross-linked by short peptides that consist of L-Ala, D-Glu,
meso-diaminopimelic acid (m-DAP), and D-Ala. In stationary phase,
D-Met (blue circles) and D-Leu (red circles) are produced by BsrV, a
periplasmic racemase. These D-amino acids (1) are incorporated at the
4th position of the PG-peptide bridge where D-Ala is usually found,
(2) regulate the activity of periplasmic enzymes including penicillin-
binding proteins (PBPs), which synthesize and modify PG, and (3) are
released into the extracellular milieu where D-amino acids regulate the
PG of other bacteria. OM Outer membrane, IM inner membrane
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123devices, such as intravascular catheters, are extremely
difﬁcult to eradicate, as the extracellular matrices protect
bioﬁlm-associated bacteria from antimicrobials and the
host immune system. Thus, discovery of new agents to
prevent bioﬁlm formation and/or disrupt established bio-
ﬁlms is of considerable interest.
B. subtilis forms bioﬁlms that can be visualized in the
laboratory as pellicles at the liquid-to-surface interface of
standing cultures or on semi-solid agar plates. Bioﬁlms on
standingculturesbegintodisassembleafter*6–8 days,and
Losick and colleagues recently reported that dissolution is
inducedbyamixtureof D-aminoacids(D-Leu, D-Met, D-Trp,
and D-Tyr) produced by B. subtilis in these bioﬁlms [78]. In
these experiments, D-amino acid accumulation was found to
be restricted to mature bioﬁlms (6–8 days) and to be pro-
duced at least in part by the racemases YlmE and RacX.
However, exogenous addition of D-amino acids to standing
cultures prevented B. subtilis bioﬁlm formation altogether.
Individually, D-Tyr showed the highest potency, but the
mixture of all four amino acids was more potent and had a
minimum inhibitory concentration of *10 nM. In contrast,
a mixture of the corresponding L-amino acids neither
inhibited bioﬁlm formation nor disrupted existing bioﬁlms
[78]. Koldkin-Gal et al. hypothesized that D-amino acid
production signals for bioﬁlm disassembly by B. subtilis
under conditions when nutrients have become limiting and
metabolicwasteproductshaveaccumulated,soescapeintoa
planktonic lifestyle is therefore beneﬁcial (Fig. 5).
The mechanisms of D-amino acid-regulated bioﬁlm
dispersal are being dissected. Koldkin-Gal et al. [78]
showed that D-amino acids can induce the disassembly of
matrix-associated amyloid ﬁbers that link B. subtilis cells
within the bioﬁlm. Maintenance of these ﬁbers seems likely
to contribute to bioﬁlm durability, since mutants that could
form bioﬁlms in the presence of D-amino acids contained
alterations within yqxM, whose gene product is required for
attachment of amyloid ﬁbers to the cell. However, it is
likely that disruption of amyloid networks is not the only
means by which D-amino acids promote bioﬁlm disas-
sembly, since Koldkin-Gal et al. found that D-amino acids
led to bioﬁlm dispersal in additional bacterial species, such
as S. aureus and P. aeruginosa, that are not known to
produce bioﬁlm matrix-associated amyloid ﬁbers. Thus, a
universal mechanism of bioﬁlm dispersal is unlikely.
Regardless of the mechanism(s) by which D-amino acids
promote bioﬁlm dispersal, use of D-amino acids to combat
bioﬁlm-associated infections holds considerable promise,
especially since D-amino acids are likely to have favorable
pharmacokinetic properties and to lack signiﬁcant toxicity
[106].
Conclusions and perspectives for future studies
Recent studies have revealed two exciting and unexpected
ﬁndings regarding D-amino acids in the bacterial kingdom.
First, highly diverse bacteria release various D-amino acids
into the environment. And second, the released D-amino
acids have heretofore unappreciated roles in regulating key
processes, including controlling stationary phase cell wall
remodeling and bioﬁlm disassembly in aging bacterial
communities. Thus, D-amino acids are signaling molecules
Early Biofilm
Late Biofilm (D-amino acid accumulation)
Biofilm Disassociation
Planktonic B. subtilis
Attachment
Fig. 5 Model of bioﬁlm life
cycle. B. subtilis cells associated
in bioﬁlm communities produce
D-amino acids (D-Tyr, D-Met,
D-Trp, and D-Leu represented
with colored circles), which
accumulate and trigger bioﬁlm
dispersal
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123that control processes that occur at high cell densities,
probably when nutrients become limited. However, the
conditions that stimulate D-amino acid production have not
been thoroughly explored; additional research is needed to
deﬁne the stimuli that promote the expression and activity
of the racemases that generate D-amino acids.
D-amino acid signaling can be regarded as both autocrine
and paracrine in nature since released D-amino acids act on
both the cells that release them as well as neighboring cells.
Inmanycases,neighboringcellsareoftheidenticalbacterial
species as the cells that produced them, but D-amino acids
can also act on nearby cells that are of different species. For
example, we found that D-Met or D-Leu could be incorpo-
rated into the PG of E. coli [77]. In addition, in nature,
bioﬁlmsarethoughttooftenconsistofmorethanonespecies
[106]. Therefore, released D-amino acids in mixed bioﬁlms
may be a paracrine signal, which, along with other chemical
regulators, control the architecture of the bacterial commu-
nity. D-amino acids may be considered as a ‘‘chemical
language’’ akin to quorum-sensing molecules, such as acyl
homoserine-lactones, that mediate interspecies communi-
cation. Itremainstobeseen whetherdifferent D-aminoacids
mediate distinct types of signals in mixed communities. For
example, D-Tyrmayprimarilyfunctionasasignalforbioﬁlm
disassembly, whereas D-Met may primarily promote cell
wall remodeling. Furthermore, D-amino acids are likely
mediatorsofmoretraditionaltypesofsignalingthatregulate
gene expression, such as the altered gene expression of
UPEC by D-serine in human urine [12].
Many intriguing questions/issues regarding the regula-
tory roles of D-amino acids in bacterial biology remain to
be addressed. Elucidating the mechanisms by which
D-amino acids govern cell wall remodeling and bioﬁlm
disassembly will undoubtedly reveal new paradigms for
understanding how processes outside of the cell membrane
are controlled. Finally, application of the regulatory roles
of D-amino acids to solve environmental and clinical
problems has considerable promise.
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